RANKINGS
Highest ROE — Healthcare
Return on Equity measures how efficiently a company generates profit from shareholder equity.
63 companies with ROE data.
Ranked by ROE(63)
| # | Ticker | Name | Market Cap | ROE |
|---|---|---|---|---|
| 1 | MBAI | $9M | 120.5% | |
| 2 | ACCL | $39M | 46.7% | |
| 3 | NIVF | $3M | 38.0% | |
| 4 | JLHL | $141M | 37.0% | |
| 5 | CGEN | $261M | 34.4% | |
| 6 | PDEX | $207M | 26.6% | |
| 7 | NNNN | $341M | 21.2% | |
| 8 | NVMI | $11.8B | 19.7% | |
| 9 | GIB | $15.4B | 17.8% | |
| 10 | ZTG | $11M | 14.5% | |
| 11 | INMD | $854M | 13.7% | |
| 12 | SNN | $12.2B | 11.8% | |
| 13 | QGEN | $9.0B | 11.2% | |
| 14 | STVN | $6.1B | 9.1% | |
| 15 | CAMT | $6.8B | 8.2% | |
| 16 | PHG | $26.3B | 7.9% | |
| 17 | AUNA | $378M | 7.5% | |
| 18 | BWAY | $579M | 4.7% | |
| 19 | ALC | $34.9B | 4.4% | |
| 20 | ZJYL | $173M | 4.0% | |
| 21 | EGG | $79M | 3.5% | |
| 22 | RYOJ | $71M | 2.0% | |
| 23 | SNDL | $336M | -1.4% | |
| 24 | BON | $9M | -3.4% | |
| 25 | INNV | $1.5B | -4.5% | |
| 26 | CCM | $21M | -4.9% | |
| 27 | WOK | $6M | -5.1% | |
| 28 | AVNS | $1.2B | -9.5% | |
| 29 | APM | $570,062.5 | -9.9% | |
| 30 | BNR | $105M | -10.1% | |
| 31 | PLRZ | $27M | -15.9% | |
| 32 | PLSM | $17M | -17.8% | |
| 33 | MITQ | $6M | -19.4% | |
| 34 | INTJ | $5M | -20.1% | |
| 35 | LITS | $34M | -28.1% | |
| 36 | POCI | $48M | -28.7% | |
| 37 | GNTA | $48M | -28.8% | |
| 38 | LICN | $20M | -31.1% | |
| 39 | RGNT | $14M | -34.3% | |
| 40 | IMTX | $1.4B | -39.1% | |
| 41 | EVAX | $26M | -45.2% | |
| 42 | NNOX | $66M | -53.7% | |
| 43 | MDWD | $171M | -54.7% | |
| 44 | DRTS | $1.4B | -55.3% | |
| 45 | ITOC | $6M | -62.7% | |
| 46 | MOLN | $178M | -73.5% | |
| 47 | RGC | $2.7B | -73.7% | |
| 48 | CLLS | $358M | -89.1% | |
| 49 | AYTU | $24M | -96.9% | |
| 50 | GLXG | $6M | -102.5% | |
| 51 | SCNI | $2M | -102.5% | |
| 52 | VALN | $622M | -104.5% | |
| 53 | SUPX | $423M | -107.0% | |
| 54 | FOFO | $18M | -112.1% | |
| 55 | SPPL | $21M | -120.0% | |
| 56 | BMRA | $6M | -149.9% | |
| 57 | ICCM | $8M | -166.4% | |
| 58 | CRDL | $241M | -185.3% | |
| 59 | BMGL | $9M | -188.7% | |
| 60 | CLGN | $5M | -188.9% | |
| 61 | ANAB | $1.7B | -210.1% | |
| 62 | PYPD | $104M | -311.4% | |
| 63 | BRTX | $5M | -470.7% |
How to turn this ranking into valuation work
Start with the company page
Validate business quality, margins, capital structure, and the current valuation context before relying on a single multiple.
Then validate WACC
A cheap multiple does not guarantee a sensible discount rate. Check cost of capital before finalizing DCF assumptions.
Finish with DCF
Use the matching DCF page to test intrinsic value so multiples, discount rates, and cash-flow assumptions stay connected.
ROE Rankings in Other Sectors
Data updated daily · Source: SEC EDGAR, Polygon.io